Results 101 to 110 of about 76,081 (145)

Maternal Respiratory Syncytial Virus Prefusion F Vaccination and Acute Respiratory Illness in Infants.

JAMA Netw Open
Rick AM, Deese J, Kerr JE, Hui J, Liu H, Yu G, Chang CH, Fazio N, Tahir MH, Bieltz R, Ravindra A, Megli C, Jeyabalan A, Pugh SJ, Patel D, Fan R, Atwell JE, Cané A, Martin JM.   +18 more
europepmc   +1 more source

Double-Stapled Peptide Scan Yields Potent Fusion Inhibitors of Respiratory Syncytial Virus. [PDF]

J Med Chem
Pidoux N, Roh L, Nicolet N, Marti R, Le Rouzic A, Prompt C, Fix J, Duquerroy S, Rey F, Rameix-Welti MA, Keck M, Barbe P, Garcin D, Mottet-Osman G, Larcher T, Galloux M, Nyanguile O.   +16 more
europepmc   +1 more source

Respiratory Syncytial Virus Hospitalizations Among Adults in Thailand: A Nationwide Retrospective Observational Study (RSV-HAT). [PDF]

Influenza Other Respir Viruses
Jarottammarat K, Pinyopornpanish K, Yan C, Mahakkanukrauh B, Cintra O, Guzman-Holst A, Phinyo P, Reechaipichitkul W.   +7 more
europepmc   +1 more source

Respiratory syncytial virus-induced SIGLEC1 upregulation inhibits macrophage autophagy and facilitates inflammatory mediator secretion. [PDF]

BMJ Open Respir Res
Lai F, Liao A, Xia K, Zhang L, Yang H, Lin W.   +5 more
europepmc   +1 more source

Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns.

JAMA
Jabagi MJ, Bertrand M, Gabet A, Kolla E, Olié V, Zureik M.   +5 more
europepmc   +1 more source

Trajectories and determinants of respiratory syncytial virus prefusion F-specific IgG in older adults. [PDF]

BMC Infect Dis
Simbeya A, Negoro M, Kuurdor ED, Sugata K, Nagao M, Ohtsuka J, Yamamoto S, Ogasawara N, Fukumura M, Nosaka T, Suga S, Taniguchi K.   +11 more
europepmc   +1 more source

Nirsevimab in High-Risk Infants in a Respiratory Syncytial Virus Prevention Strategy.

JAMA Netw Open
Sauré D, Torres JP, Goic M, Thraves C, Pacheco J, Burgos J, Zgheib A, Del Solar F, Neira I, O'Ryan M, Basso LJ.   +10 more
europepmc   +1 more source

Acceptance of the respiratory syncytial virus infant monoclonal antibody nirsevimab among post-partum women in Italy. [PDF]

Hum Vaccin Immunother
Angelillo S, Miraglia Del Giudice G, Della Polla G, Angelillo IF, Collaborative Working Group.   +4 more
europepmc   +1 more source

Comparative analysis of ARIMA and Holt-Winter's additive models for describing human respiratory syncytial virus activity in Yaoundé, Cameroon. [PDF]

Int J Public Health
Moumbeket-Yifomnjou MH, Monamele CG, Tsafack DT, Njankouo MR, Mounchili-Njifon A, Tagnouokam-Ngoupo PA, Modiyinji AF, Onana B, Njouom R.   +8 more
europepmc   +1 more source

Mathematical analysis of a stochastic delay model for respiratory syncytial virus dynamics. [PDF]

Sci Rep
Raza A, Lampart M, Shafique U, Alfwzan WF, Fadhal E.   +4 more
europepmc   +1 more source